Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
HIV Medicine & Life Sciences
Dengue Vaccines Medicine & Life Sciences
Infection Medicine & Life Sciences
Dengue Virus Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Viremia Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
HIV-1 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2016

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response

Durbin, A. P., Kirkpatrick, B. D., Pierce, K. K., Carmolli, M. P., Tibery, C. M., Grier, P. L., Hynes, N., Opert, K., Jarvis, A. P., Sabundayo, B. P., McElvany, B. D., Sendra, E. A., Larsson, C. J., Jo, M., Lovchik, J. M., Luke, C. J., Walsh, M. C., Fraser, E. A., Subbarao, K. & Whitehead, S. S. Sep 15 2016 In : Journal of Infectious Diseases. 214, 6, p. 832-835 4 p.

Research output: Research - peer-reviewArticle

Dengue Vaccines
National Institute of Allergy and Infectious Diseases (U.S.)
Neutralizing Antibodies
Antibody Formation
Vaccines

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

Kirkpatrick, B. D., Whitehead, S. S., Pierce, K. K., Tibery, C. M., Grier, P. L., Hynes, N. A., Larsson, C. J., Sabundayo, B. P., Talaat, K. R., Janiak, A., Carmolli, M. P., Luke, C. J., Diehl, S. A. & Durbin, A. P. Mar 16 2016 In : Science Translational Medicine. 8, 330, 330RA36

Research output: Research - peer-reviewArticle

Dengue Vaccines
Attenuated Vaccines
Dengue
Dengue Virus
Viremia

Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults

Kirkpatrick, B. D., Durbin, A. P., Pierce, K. K., Carmolli, M. P., Tibery, C. M., Grier, P. L., Hynes, N., Diehl, S. A., Elwood, D., Jarvis, A. P., Sabundayo, B. P., Lyon, C. E., Larsson, C. J., Jo, M., Lovchik, J. M., Luke, C. J., Walsh, M. C., Fraser, E. A., Subbarao, K. & Whitehead, S. S. 2015 In : Journal of Infectious Diseases. 212, 5, p. 702-710 9 p.

Research output: Research - peer-reviewArticle

Dengue Vaccines
Flavivirus
Dengue Virus
Vaccines
Serogroup

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: A randomized, double-blind clinical trial

Durbin, A. P., Kirkpatrick, B. D., Pierce, K. K., Elwood, D., Larsson, C. J., Lindow, J. C., Tibery, C., Sabundayo, B. P., Shaffer, D., Talaat, K. R., Hynes, N. A., Wanionek, K., Carmolli, M. P., Luke, C. J., Murphy, B. R., Subbarao, K. & Whitehead, S. S. 2013 In : Journal of Infectious Diseases. 207, 6, p. 957-965 9 p.

Research output: Research - peer-reviewArticle

Dengue Vaccines
Flavivirus
Dengue Virus
Clinical Trials
Exanthema

Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy

Byrnes, A. A., Harris, D. M., Atabani, S. F., Sabundayo, B. P., Langan, S. J., Margolick, J. B. & Karp, C. L. Dec 1 2008 In : Journal of Leukocyte Biology. 84, 6, p. 1447-1453 7 p.

Research output: Research - peer-reviewArticle

Highly Active Antiretroviral Therapy
Interleukin-12
HIV Infections
Biomarkers
T-Lymphocytes